116 related articles for article (PubMed ID: 4392950)
1. Clandestine drug laboratories.
Gunn JW; Johnson DW; Butler WP
J Forensic Sci; 1970 Jan; 15(1):51-64. PubMed ID: 4392950
[No Abstract] [Full Text] [Related]
2. The clandestine drug laboratory situation in the United States.
Frank RS
J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
[TBL] [Abstract][Full Text] [Related]
3. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
Grant P; Bell K; Stewart D; Paulson J; Rogers K
Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
[TBL] [Abstract][Full Text] [Related]
4. Pseudoephedrine laws in the US--are we doing enough?
Murty S; Sansgiry SS
Ann Pharmacother; 2006 Jun; 40(6):1213-5. PubMed ID: 16735651
[No Abstract] [Full Text] [Related]
5. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine.
Irvine GD; Chin L
NIDA Res Monogr; 1991; 115():33-46. PubMed ID: 1758481
[No Abstract] [Full Text] [Related]
6. Epidemiology of methamphetamine abuse in Missouri.
Topolski JM
Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
[TBL] [Abstract][Full Text] [Related]
7. The holy grail of supply control: have we found the evidence?
McKetin R
Addiction; 2009 Mar; 104(3):455-6. PubMed ID: 19207355
[No Abstract] [Full Text] [Related]
8. How to expand the 'sample size' of studies of drug market disruptions.
Caulkins J
Addiction; 2009 Mar; 104(3):454-5. PubMed ID: 19207354
[No Abstract] [Full Text] [Related]
9. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
Colker AC
NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
[No Abstract] [Full Text] [Related]
10. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
Boulard G
State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
[No Abstract] [Full Text] [Related]
11. Methamphetamine precursor regulation: are we controlling or diverting the drug problem?
McKetin R
Addiction; 2008 Apr; 103(4):521-3. PubMed ID: 18339098
[No Abstract] [Full Text] [Related]
12. Clinical effects and management of methamphetamine abuse.
Romanelli F; Smith KM
Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
[TBL] [Abstract][Full Text] [Related]
13. The computer's role in the laboratories of the Drug Enforcement Administration.
Johnson DW; Gunn JW
J Forensic Sci; 1975 Jul; 20(3):564-70. PubMed ID: 1151317
[No Abstract] [Full Text] [Related]
14. [Control of stupefacient drugs].
Rolland B
Arch Belg Med Soc; 1970 Apr; 28(4):249-56. PubMed ID: 4395264
[No Abstract] [Full Text] [Related]
15. Commerce in drugs and chemicals and the detection of clandestine laboratories.
Haislip GR
Bull Narc; 1984; 36(1):25-31. PubMed ID: 6564900
[TBL] [Abstract][Full Text] [Related]
16. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States.
Cunningham JK; Liu LM; Callaghan R
Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353
[TBL] [Abstract][Full Text] [Related]
17. [Effective control of dependence-developing drugs within reach].
Bengtsson H
Lakartidningen; 1971 Dec; 68(49):5657-9. PubMed ID: 4400248
[No Abstract] [Full Text] [Related]
18. Methamphetamine and its impact on dental care.
Klasser GD; Epstein J
J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
[TBL] [Abstract][Full Text] [Related]
19. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
Fed Regist; 1999 May; 64(92):25910-2. PubMed ID: 10558537
[TBL] [Abstract][Full Text] [Related]
20. Cooking up solutions to a cooked up menace: responses to methamphetamine in a federal system.
Harv Law Rev; 2006 Jun; 119(8):2508-29. PubMed ID: 16827221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
